Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do.
Higgins
Michaela J
MJ
Breast Cancer Program, The Sidney Kimmel Comprehensive Cancer Center, John Hopkins, Baltimore, Maryland, USA.
Wolf
Antonio C
AC
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D010053:Ovary / Q000187:drug effects; D017697:Premenopause; D011960:Receptors, Estrogen / Q000032:analysis*; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen; D013629:Tamoxifen; D017273:Goserelin